Silibinin Effects on Cognitive Enhancement and Neurotrophic Factor Modulation in an Alzheimer’s Disease Model Induced by Amyloid Beta in Rats

How to Cite:Azizi M, Salari S, Bagheri M, Silibinin Effects on Cognitive Enhancement and Neurotrophic Factor Modulation in an Alzheimer’s Disease Model Induced by Amyloid Beta in Rats.koomesh.2025;26(6):e149415.https://doi.org/10.69107/koomesh-149415.

Abstract

Background: Alzheimer's disease (AD) is the most common cause of dementia. Herbal medicines are increasingly recognized as alternative therapies with lower side effects.
Objectives: This study aimed to investigate the protective effects of silibinin on cognitive function and the expression of neurotrophic factors in a rat model of AD.
Methods: Male Wistar rats (n = 40) were assigned to the sham group, lesion (Aβ1-40 injection), treatment group (Aβ1-40 injection followed by silibinin gavage in doses of 50 and 100 mg/kg), and vehicle group. The cognitive performance of the groups was evaluated using the Morris Water Maze behavioral test. Subsequently, brain tissue homogenates were prepared to measure BDNF and VEGF expression levels using the western blot technique. Also, the brain slices were stained with the Nissl technique and the neurons were counted in the hippocampal regions.
Results: The mean number of neurons in the CA1 region in the lesion group was significantly reduced compared to the sham group (P = 0.004), however, treatment with silibinin has significantly increased the number of neurons in this region compared to the lesion group (P = 0.0002). Also, treatment with silibinin led to a significant increase in the levels of neurotrophic VEGF, and BDNF in the treated groups compared to the lesion group (P ≤ 0.05).
Conclusion:Findings showed the potential of silibinin in reducing the symptoms associated with Alzheimer's and protecting hippocampal neurons against disease-related damage by increasing the levels of BDNF and VEGF growth factors in the brain.

Keywords

Alzheimer Disease

Silibinin

Amyloid beta-Peptides

Brain-Derived Neurotrophic Factor

Vascular Endothelial Growth Factor

References

1.
Mansergh FC, Wride MA, Rancourt DE. Neurons from stem cells: implications for understanding nervous system development and repair. Biochem Cell Biol. 2000;78(5):613-28. [PubMed ID:11103952].
2.
Stix G. Alzheimer's: forestalling the darkness. Sci Am. 2010;302(6):50-7. [PubMed ID:20521480]. https://doi.org/10.1038/scientificamerican0610-50.
3.
Giuffrida ML, Copani A, Rizzarelli E. A promising connection between BDNF and Alzheimer's disease. Aging (Albany NY). 2018;10(8):1791-2. [PubMed ID:30082505]. [PubMed Central ID:PMC6128436]. https://doi.org/10.18632/aging.101518.
4.
Gao L, Zhang Y, Sterling K, Song W. Brain-derived neurotrophic factor in Alzheimer's disease and its pharmaceutical potential. Transl Neurodegener. 2022;11(1):4. [PubMed ID:35090576]. [PubMed Central ID:PMC8796548]. https://doi.org/10.1186/s40035-022-00279-0.
5.
Xue B, Waseem SMA, Zhu Z, Alshahrani MA, Nazam N, Anjum F, et al. Brain-Derived Neurotrophic Factor: A Connecting Link Between Nutrition, Lifestyle, and Alzheimer's Disease. Front Neurosci. 2022;16:925991. [PubMed ID:35692417]. [PubMed Central ID:PMC9177140]. https://doi.org/10.3389/fnins.2022.925991.
6.
Ng TKS, Ho CSH, Tam WWS, Kua EH, Ho RC. Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer's Disease (AD): A Systematic Review and Meta-Analysis. Int J Mol Sci. 2019;20(2). [PubMed ID:30634650]. [PubMed Central ID:PMC6358753]. https://doi.org/10.3390/ijms20020257.
7.
Schulz V, Hänsel R, Tyler VE. Rational phytotherapy: a physician's guide to herbal medicine. East Sussex, England: Psychology Press; 2001.
8.
Mateen S, Tyagi A, Agarwal C, Singh RP, Agarwal R. Silibinin inhibits human nonsmall cell lung cancer cell growth through cell-cycle arrest by modulating expression and function of key cell-cycle regulators. Mol Carcinog. 2010;49(3):247-58. [PubMed ID:19908243]. [PubMed Central ID:PMC3049548]. https://doi.org/10.1002/mc.20595.
9.
Baluchnejadmojarad T, Roghani M, HomayonFar H, KhastKhodaei Z. [Protective effects of chronic administration of silymarin on blood glucose and lipids and oxidative stress in diabetic rats]. koomesh. 2009;10(2):e152232. Persian.
10.
Baluchnejadmojarad T, Roghani M, Mafakheri M. Neuroprotective effect of silymarin in 6-hydroxydopamine hemi-parkinsonian rat: involvement of estrogen receptors and oxidative stress. Neurosci Lett. 2010;480(3):206-10. [PubMed ID:20600617]. https://doi.org/10.1016/j.neulet.2010.06.038.
11.
Geed M, Garabadu D, Ahmad A, Krishnamurthy S. Silibinin pretreatment attenuates biochemical and behavioral changes induced by intrastriatal MPP+ injection in rats. Pharmacol Biochem Behav. 2014;117:92-103. [PubMed ID:24345573]. https://doi.org/10.1016/j.pbb.2013.12.008.
12.
Hou YC, Liou KT, Chern CM, Wang YH, Liao JF, Chang S, et al. Preventive effect of silymarin in cerebral ischemia-reperfusion-induced brain injury in rats possibly through impairing NF-kappaB and STAT-1 activation. Phytomedicine. 2010;17(12):963-73. [PubMed ID:20833521]. https://doi.org/10.1016/j.phymed.2010.03.012.
13.
Jangra A, Kasbe P, Pandey SN, Dwivedi S, Gurjar SS, Kwatra M, et al. Hesperidin and Silibinin Ameliorate Aluminum-Induced Neurotoxicity: Modulation of Antioxidants and Inflammatory Cytokines Level in Mice Hippocampus. Biol Trace Elem Res. 2015;168(2):462-71. [PubMed ID:26018497]. https://doi.org/10.1007/s12011-015-0375-7.
14.
Song X, Zhou B, Cui L, Lei D, Zhang P, Yao G, et al. Silibinin ameliorates Abeta(25-35)-induced memory deficits in rats by modulating autophagy and attenuating neuroinflammation as well as oxidative stress. Neurochem Res. 2017;42(4):1073-83. [PubMed ID:28004303]. https://doi.org/10.1007/s11064-016-2141-4.
15.
Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. Cambridge, Massachusetts: Academic Press; 1998.
16.
Bagheri M, Roghani M, Joghataei MT, Mohseni S. Genistein inhibits aggregation of exogenous amyloid-beta(1)(-)(4)(0) and alleviates astrogliosis in the hippocampus of rats. Brain Res. 2012;1429:145-54. [PubMed ID:22079317]. https://doi.org/10.1016/j.brainres.2011.10.020.
17.
Torres-Rodriguez A, Darvishzadeh R, Skidmore AK, Franzel-Luiten E, Knaken B, Schuur B. High-throughput Soxhlet extraction method applied for analysis of leaf lignocellulose and non-structural substances. MethodsX. 2024;12:102644. [PubMed ID:38660031]. [PubMed Central ID:PMC11041828]. https://doi.org/10.1016/j.mex.2024.102644.
18.
Bagheri M, Rezakhani A, Nystrom S, Turkina MV, Roghani M, Hammarstrom P, et al. Amyloid beta(1-40)-induced astrogliosis and the effect of genistein treatment in rat: a three-dimensional confocal morphometric and proteomic study. PLoS One. 2013;8(10):e76526. [PubMed ID:24130779]. [PubMed Central ID:PMC3793933]. https://doi.org/10.1371/journal.pone.0076526.
19.
Bagheri M, Rezakhani A, Roghani M, Joghataei MT, Mohseni S. Protocol for Three-dimensional Confocal Morphometric Analysis of Astrocytes. J Vis Exp. 2015(106):e53113. [PubMed ID:26709729]. [PubMed Central ID:PMC4692798]. https://doi.org/10.3791/53113.
20.
Shankar GM, Walsh DM. Alzheimer's disease: synaptic dysfunction and Abeta. Mol Neurodegener. 2009;4:48. [PubMed ID:19930651]. [PubMed Central ID:PMC2788538]. https://doi.org/10.1186/1750-1326-4-48.
21.
Carrillo-Mora P, Luna R, Colin-Barenque L. Amyloid beta: multiple mechanisms of toxicity and only some protective effects? Oxid Med Cell Longev. 2014;2014:795375. [PubMed ID:24683437]. [PubMed Central ID:PMC3941171]. https://doi.org/10.1155/2014/795375.
22.
Guo H, Cao H, Cui X, Zheng W, Wang S, Yu J, et al. Silymarin's Inhibition and Treatment Effects for Alzheimer's Disease. Molecules. 2019;24(9). [PubMed ID:31064071]. [PubMed Central ID:PMC6539875]. https://doi.org/10.3390/molecules24091748.
23.
Lima Giacobbo B, Doorduin J, Klein HC, Dierckx R, Bromberg E, de Vries EFJ. Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation. Mol Neurobiol. 2019;56(5):3295-312. [PubMed ID:30117106]. [PubMed Central ID:PMC6476855]. https://doi.org/10.1007/s12035-018-1283-6.
24.
Nowacka M, Obuchowicz E. BDNF and VEGF in the pathogenesis of stress-induced affective diseases: an insight from experimental studies. Pharmacol Rep. 2013;65(3):535-46. [PubMed ID:23950576]. https://doi.org/10.1016/s1734-1140(13)71031-4.
25.
Song X, Liu B, Cui L, Zhou B, Liu W, Xu F, et al. Silibinin ameliorates anxiety/depression-like behaviors in amyloid beta-treated rats by upregulating BDNF/TrkB pathway and attenuating autophagy in hippocampus. Physiol Behav. 2017;179:487-93. [PubMed ID:28735062]. https://doi.org/10.1016/j.physbeh.2017.07.023.
26.
Baluchnejadmojarad T, Roghani M, Mafakheri M. [Protective effects of aqueous extract of silybum marianum in 6-hydroxydopamine-induced model of parkinsonism in male rat: a behavioral, biochemical and histological study]. koomesh. 2011;12(4):e152481. Persian.
27.
Yon B, Belviranli M, Okudan N. The effect of silymarin supplementation on cognitive impairment induced by diabetes in rats. J Basic Clin Physiol Pharmacol. 2019;30(4). [PubMed ID:31017870]. https://doi.org/10.1515/jbcpp-2018-0109.
28.
Liu P, Wang C, Chen W, Kang Y, Liu W, Qiu Z, et al. Inhibition of GluN2B pathway is involved in the neuroprotective effect of silibinin on streptozotocin-induced Alzheimer's disease models. Phytomedicine. 2023;109:154594. [PubMed ID:36610115]. https://doi.org/10.1016/j.phymed.2022.154594.
29.
Duan S, Guan X, Lin R, Liu X, Yan Y, Lin R, et al. Silibinin inhibits acetylcholinesterase activity and amyloid beta peptide aggregation: a dual-target drug for the treatment of Alzheimer's disease. Neurobiol Aging. 2015;36(5):1792-807. [PubMed ID:25771396]. https://doi.org/10.1016/j.neurobiolaging.2015.02.002.

comments

Crossmark

Checking

Share on

Comments

Number of Comments:0

Cited by

CrossRef 0

Metrics

Get Permission (article level)

Purchasing Reprints

Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here ( https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.

Search Relations

Author(s):

Monireh Azizi:[PubMed][Scholar]
Sajjad Salari:[PubMed][Scholar]
Maryam Bagheri:[PubMed][Scholar]